The correlation of galectin-3 with the parameters characterizing obesity, the lipid profile and the level of glycemia, once again emphasizes the close relationship of this biomarker with the components of MS and enlargement of atrial volumes is also associated with an increase galectin-3 concentration, which also contributes to the risk of AF. Here, LGALS3 is linked to obesity disorder.